Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-21

Clinical Trial Update: The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized, double-blind, placebo-controlled trial evaluated intravenous mannitol plus saline for preventing cisplatin-induced nephrotoxicity across Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mannitol (mannitol)
  • Saline (Sodium chloride solution)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Cis-Platinum Nephropathy, Mannitol Adverse Reaction | Phase 2, Phase 3 | Status: COMPLETED